154 related articles for article (PubMed ID: 17885671)
1. Patterns of spectrin expression in B-cell lymphomas: loss of spectrin isoforms is associated with nodule-forming and germinal center-related lymphomas.
Gorman EB; Chen L; Albanese J; Ratech H
Mod Pathol; 2007 Dec; 20(12):1245-52. PubMed ID: 17885671
[TBL] [Abstract][Full Text] [Related]
2. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
3. Spectrin isoforms: differential expression in normal hematopoiesis and alterations in neoplastic bone marrow disorders.
Wolgast LR; Cannizzarro LA; Ramesh KH; Xue X; Wang D; Bhattacharyya PK; Gong JZ; McMahon C; Albanese JM; Sunkara JL; Ratech H
Am J Clin Pathol; 2011 Aug; 136(2):300-8. PubMed ID: 21757604
[TBL] [Abstract][Full Text] [Related]
4. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B-cell proliferations is of diagnostic value.
Wang T; Lasota J; Hanau CA; Miettinen M
APMIS; 1995 Sep; 103(9):655-62. PubMed ID: 7488387
[TBL] [Abstract][Full Text] [Related]
6. Utilization of spectrins βI and βIII in diagnosis of hepatocellular carcinoma.
Hu S; Jue D; Albanese J; Wang Y; Liu Q
Ann Diagn Pathol; 2019 Apr; 39():86-91. PubMed ID: 30798076
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.
Nam-Cha SH; Montes-Moreno S; Salcedo MT; Sanjuan J; Garcia JF; Piris MA
Mod Pathol; 2009 Aug; 22(8):1006-15. PubMed ID: 19465900
[TBL] [Abstract][Full Text] [Related]
8. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
[TBL] [Abstract][Full Text] [Related]
10. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
Dogan A; Bagdi E; Munson P; Isaacson PG
Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
[TBL] [Abstract][Full Text] [Related]
11. Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues.
Kodali D; Rawal A; Ninan MJ; Patel MR; Mesa H; Knapp D; Schnitzer B; Kratzke RA; Gupta P
Arch Pathol Lab Med; 2011 Mar; 135(3):365-71. PubMed ID: 21366462
[TBL] [Abstract][Full Text] [Related]
12. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
[TBL] [Abstract][Full Text] [Related]
13. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
14. The leukocyte semaphorin CD100 is expressed in most T-cell, but few B-cell, non-Hodgkin's lymphomas.
Dorfman DM; Shahsafaei A; Nadler LM; Freeman GJ
Am J Pathol; 1998 Jul; 153(1):255-62. PubMed ID: 9665486
[TBL] [Abstract][Full Text] [Related]
15. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
16. p53 expression in lymphatic malignancies.
Soini Y; Pääkkö P; Alavaikko M; Vähäkangas K
J Clin Pathol; 1992 Nov; 45(11):1011-4. PubMed ID: 1452775
[TBL] [Abstract][Full Text] [Related]
17. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
18. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
Kamel OW; Gelb AB; Shibuya RB; Warnke RA
Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclin D2 and D3 in lymphoid lesions.
Teramoto N; Pokrovskaja K; Szekely L; Polack A; Yoshino T; Akagi T; Klein G
Int J Cancer; 1999 May; 81(4):543-50. PubMed ID: 10225442
[TBL] [Abstract][Full Text] [Related]
20. Reed-Sternberg-like cells in low-grade lymphomas are transformed neoplastic cells of B-cell lineage.
Shin SS; Ben-Ezra J; Burke JS; Sheibani K; Rappaport H
Am J Clin Pathol; 1993 Jun; 99(6):658-62. PubMed ID: 8322699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
